Back to Journals » Clinical Ophthalmology » Volume 3

Bevacizumab (Avastin®) for the management of anterior chamber neovascularization and neovascular glaucoma
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
8,490 | Dovepress* | 8,490 | 0+ | 3,183 | 8,490 |
Totals | 8,490 | 0 | 3,183 | 8,490 | |
*Since 20 November 2009 +Since July 2016 |
View citations on Google Scholar